U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H20N2O4
Molecular Weight 292.3303
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHF-6366 .beta.-2 metabolite

SMILES

OCCCCNC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1

InChI

InChIKey=LAXUZKBMSNSUBP-ZDUSSCGKSA-N
InChI=1S/C15H20N2O4/c18-8-2-1-7-16-9-13(20)10-3-5-12(19)15-11(10)4-6-14(21)17-15/h3-6,13,16,18-20H,1-2,7-9H2,(H,17,21)/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula C15H20N2O4
Molecular Weight 292.3303
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:18:33 UTC 2023
Edited
by admin
on Sat Dec 16 19:18:33 UTC 2023
Record UNII
F9CEF23GHV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHF-6366 .beta.-2 metabolite
Code English
Code System Code Type Description
FDA UNII
F9CEF23GHV
Created by admin on Sat Dec 16 19:18:33 UTC 2023 , Edited by admin on Sat Dec 16 19:18:33 UTC 2023
PRIMARY
PUBCHEM
166177238
Created by admin on Sat Dec 16 19:18:33 UTC 2023 , Edited by admin on Sat Dec 16 19:18:33 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY
This fragment showed a rapid onset as well but exerted only one-half the effect of the full MABA at the same time point. However, this effect was short lasting with a significant reduction in bronchoconstriction inhibition observed at the next time point.